ZNF703 facilitates HCC invasion and metastasis by inducing EMT by way of transactivating CLDN4 expression, which is subsequently shown to mediate this EMT and sorafenib resistance. The gene discussed is CLDN4; the disease is hepatocellular carcinoma.